As the market moves rapidly toward value-based care, one cardiology physician describes how working with New Century Health gave his practice the confidence and support to succeed in an advanced alternative payment model.
Other content in this Stream
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
Evolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions
The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.
Hitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
Top Takeaways from the 2021 ASCO Annual Meeting
Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.
New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
Traditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.
Senior Medical Director Fernando Villacian lays out the key tenets of an effective cardiovascular management program.
In this podcast series we explore the trends and forces behind the two leading causes of death in the United States: cancer and heart disease.
Our senior medical director speaks with Journal of Clinical Pathways about preventing inappropriate use in cardiology.
New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.
Can Clinical Pathways Help Combat Health Care Disparities?
A new research effort aims to gauge whether certain groups of patients receive high-value therapies at lower rates than others.
Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.
Evolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors
Evolent Health, Parent Company of New Century Health, Names Kim Keck to Board of Directors. Announces Cheryl Scott to Serve as Lead Independent Director.
Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent
NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.
New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.
New Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services
The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.
New Century Health’s John Davis hosts a virtual “fireside chat” with Dr. Elizabeth Malko, Dr. Vinay Prasad, and Dr. Andrew Hertler.